Luigi Brunetti, PharmD, BCPS, CGP
Clinical Associate Professor
Department of Pharmacy Practice and Administration
William Levine Hall, Rm 412
Phone: (848) 445 6827
Specialty: Internal Medicine
Practice site: Robert Wood Johnson University Hospital - Somerset
PharmD, Philadelphia College of Pharmacy
Dr. Brunetti received a Bachelor of Science degree in Biology from Saint Peter’s College in 2000. While managing a medication adherence program developed by University Research Associates in Englewood Cliffs, New Jersey, he became deeply interested in pharmacotherapy. Based on this experience, Dr. Brunetti enrolled at the Philadelphia College of Pharmacy, where he completed the Doctor of Pharmacy program in 2006. Subsequently, he completed a specialized residency in Drug Information Practice at Robert Wood Johnson University Hospital. In 2012, Dr. Brunetti completed a Master in Public Health degree with a concentration in epidemiology at the School of Public Health, Rutgers University (formerly the University of Medicine and Dentistry of New Jersey). Dr. Brunetti is a Board Certified Pharmacotherapy Specialist and a Certified Geriatric Pharmacist.
Dr. Brunetti serves as a preceptor for both Internal Medicine and Anticoagulation Advanced Pharmacy Practice Experiential (APPE) learning clerkships for Rutgers pharmacy students. He lectures in several courses ranging in content from men’s health to neurologic disease. He also serves as a lecturer for the Graduate Nutrition Program at Rutgers University. In addition, Dr. Brunetti is an active lecturer in continuing education programs directed towards pharmacists, physicians, and nurses.
Robert Wood Johnson University Hospital Somerset awarded Dr. Brunetti with the 2011 Family Medicine Teacher of the Year Award and the 2012 Friend of Nursing Award. These awards illustrate his dedication to collaborative work and breaking down barriers to improve patient care.
Focus on medication safety, anticoagulation, and internal medicine.
Brunetti L, Chen C, White J. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population. Consult Pharm 2014;29(3):169-78.
Kim D, Barna R, Barna-Bridgeman M, Brunetti L. Novel oral anticoagulants for stroke prevention in the geriatric population. Am J Cardiovasc Drugs 2014;14(1):15-29.
Kalabalik J, Brunetti L, El-Srougy R. Intensive care unit delirium: a review of the literature. J Pharm Pract 2014; 27(2):195-207.
Davis L, Brunetti L, Lee EK, Yoon N, Cho SH, Suh DC. Effects of computerized physician order entry on medication turnaround time and orders requiring pharmacist intervention. Res Social Adm Pharm 2013; (In Press).
Brunetti L, Maroney M, Wagner M, Ryan M. Teriflunomide for the treatment of relapsing multiple sclerosis: a review of clinical data. Ann Pharmacother 2013; 47:1153-60.
Brunetti L, Bandali F. Dabigatran: Is there a role for coagulation assays in guiding therapy? Ann Pharmacother 2013; 47(6):828-40.
Brunetti L, Kalabalik J. Management of type 2 diabetes mellitus in adults: focus on individualizing non-insulin therapies P&T Journal 2012;37:687-96.
Brunetti L, Suh DC. Medication errors: scope and prevention strategies. J Hosp Admin 2012; 1(2):54-63.
Brunetti L, Molinelli P. Treatment of acquired hemophilia. US Pharm 2012; 37(3)(Oncology suppl):3-7.
Torro J, Brunetti L, Patel M. Iontophoretic administration of dexamethasone for musculoskeletal pain. J Musculoskel Med. 2011;28:410-421.
Brunetti L, Campbell RK. Clinical efficacy of colesevelam in type 2 diabetes mellitus. J Pharm Pract. 2011;24:417-25.
Patel M, Brunetti L. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine intolerant patient: case report and review. Am J Health-Sys Pharm 2010;67:1154-9.
Brunetti L, Hermes-DeSantis ER. C. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus. Ann Pharmacother 2010;44:1196-206.
Brunetti L, Hermes-DeSantis ER. The Internet as a drug information resource. US Pharm 2010;35(1):Epub.
Brunetti L, Hermes-DeSantis ER, Stibal D, Mollinelli P. Optimizing the Use of Hematologic Agents: A Case-Based Approach Highlighting the Use of IVIG, Hemin, and Azacitidine. US Pharm 2010;35(1)(Oncology suppl):4-12.
Brunetti L, Hermes-DeSantis ER. Treatment of viral myocarditis caused by coxsackievirus B Am J Health-Sys Pharm 2008;65:132-7.
Brunetti L, Santell J, Hicks R. Assessing the impact of abbreviations on patient safety. Jt Comm J Qual Saf 2007;33(9):576-83.